Jagsonpal Pharmaceuticals Share Price

₹ 215.90

-₹0.19 (-0.09%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: JAGSNPHARM
|
Pharmaceuticals

Jagsonpal Pharmaceuticals Share Price Today

As of 3 Nov 2026, Jagsonpal Pharmaceuticals share price is ₹215.90. The stock opened at ₹216.80, compared to its previous close of ₹216.09. During today's trading session, Jagsonpal Pharmaceuticals share price moved in the range of ₹214.71 to ₹219.40, with an average price of ₹217.06 for the day. Looking at its last 52-week, the stock has touched a low of ₹155.00 and a high of ₹264.50. On the performance front, Jagsonpal Pharmaceuticals share price has increased by 2.83% over the last six months and is down 2.92% on a year-on-year basis.

Share price over the last 1 day fell from 216.80 to 215.90, ranging between 214.71 and 218.54.
₹214.71
0.09% down today
₹219.40
1D LOW
1D HIGH

Jagsonpal Pharmaceuticals Stock Insights

Stock Performance
OutperformingBeat Nifty by 5.93 % in last 6 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.34%
Shareholding Pattern
DIIDII decreased stake by 99.52%
Shareholding Pattern
FIIFII decreased stake by 7.01%
Jagsonpal Pharmaceuticals stock performance
Open₹216.80
High₹219.40
Low₹214.71
Prev. close₹216.09
Jagsonpal Pharmaceuticals trading activity
Volume27,495
Average traded price₹216.59
Last traded time03:29:53 02 Nov
Last traded quantity22
Circuit
L
H
₹173.07
₹259.59
52-week
L
H
₹155.00
₹264.50
Mkt Cap Cr
1,432.83
P/E
31.31
P/B
5.84
ROA
15.4%
ROE
18.66%
ROCE
24.6%
Quick Ratio
4.54
EV/EBITDA
18.78

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Jagsonpal Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Jagsonpal Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Jagsonpal Pharmaceuticals Company Background

ISIN
INE048B01035
Sector Market Cap
₹ 1,432.83 Cr

Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.

Jagsonpal Pharmaceuticals Financial Highlights

  • Revenue: Jagsonpal Pharmaceuticals reported revenue of ₹299.23 crore in FY26 vs ₹276.91 crore in FY25. It showed an increase of 8.06% on a yearly basis.
  • Operating Profit: Jagsonpal Pharmaceuticals reported an operating profit of ₹57.52 crore in FY26 vs ₹69.86 crore in FY25. It showed a decrease of 17.66% on a year-on-year basis.
  • Net Profit: Jagsonpal Pharmaceuticals reported a net profit of ₹43.08 crore in FY26 vs ₹55.36 crore in FY25. It showed a decrease of 22.18% on a yearly basis.

Jagsonpal Pharmaceuticals Quarterly Result Highlights

  • Jagsonpal Pharmaceuticals reported revenue of ₹83.61 crore in Sep 2026, compared with ₹85.06 crore in Jun 2026, representing a decrease of 1.70% on a quarter-on-quarter (QoQ) basis.
  • Jagsonpal Pharmaceuticals reported an operating profit of ₹16.83 crore in Sep 2026, compared with ₹17.68 crore in Jun 2026, representing a decrease of 4.81% on a quarter-on-quarter (QoQ) basis.
  • Jagsonpal Pharmaceuticals reported a profit of ₹12.59 crore in Sep 2026, compared with ₹13.19 crore in Jun 2026, reflecting a decrease of 4.55% on a QoQ basis.
  • The earnings per share (EPS) of Jagsonpal Pharmaceuticals stood at ₹6.40 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
68.81%
FII
2.14%
Other DII
0.00%
Retail and other
29.04%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20252.12%
Mar 20262.44%
Jun 20262.30%
Sep 20262.14%

Jagsonpal Pharmaceuticals Investment Returns

1 day
+0.11%
1 week
-3.02%
1 month
-6.65%
1 year
-2.92%
3 years
+31.03%
5 years
+204.52%

Jagsonpal Pharmaceuticals Share Price History

Jagsonpal Pharmaceuticals share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹216.80 / ₹216.33
+0.11%
30 Oct 26
₹222.00 / ₹216.09
-2.64%
29 Oct 26
₹219.52 / ₹221.94
-3.91%
28 Oct 26
₹225.10 / ₹230.96
+3.52%
Show more

Jagsonpal Pharmaceuticals Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹287.23₹268.72₹208.70₹236.71
Other Income₹12.00₹8.19₹9.28₹5.73
Total Revenue₹299.22₹276.91₹217.98₹242.45
Total Expenses₹239.62₹226.73₹188.11₹204.18
Profit Before Tax₹57.52₹69.86₹29.87₹34.81
Tax₹14.44₹14.50₹7.41₹8.09
Profit After Tax₹43.08₹55.36₹22.46₹26.72
EPS - Basic₹6.40₹8.26₹3.40₹10.20
EPS - Diluted₹6.31₹8.22₹3.39₹10.20

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹57.52₹69.86₹29.87₹34.81
Income before WC changes₹61.10₹57.92₹38.14₹44.44
Change in Assets-₹4.36-₹1.66₹11.12₹9.39
Change in Liabilities₹1.97₹7.00-₹5.58₹0.10
Change in WC-₹2.39₹5.34₹5.54₹9.50
Cash flow from Operations₹46.81₹55.11₹35.17₹46.66
Cash flow from Investing-₹35.65-₹45.15-₹24.55-₹57.67
Cash flow from Financing-₹12.15-₹11.70-₹8.91-₹0.46
Total Cash Flow-₹0.99-₹1.73₹1.71-₹11.47
Cash (Start of the year)₹11.03₹12.76₹11.05₹22.53
Cash (End of the year)₹10.04₹11.03₹12.76₹11.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹173.59₹117.07₹20.30₹30.39
Current Assets₹143.09₹161.19₹196.78₹164.56
Total Assets₹316.68₹278.26₹217.08₹194.95
Current Liabilities₹28.30₹25.90₹19.13₹27.57
Net Current Asset₹114.79₹135.29₹177.65₹136.99
Non-Current Liabilities₹12.21₹12.41₹10.55₹8.49
Equity Capital₹276.17₹239.95₹187.40₹158.89
Total Equity & Liabilities₹316.68₹278.26₹217.08₹194.95
* All values are in INR Crore
Jagsonpal Pharmaceuticals market depth
Bid quantityBid priceAsk priceAsk quantity
00216.33305
0000
0000
0000
0000
Total bid quantity0
Total ask quantity305
Jagsonpal Pharmaceuticals technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
41.86
Neutral
ATR (14)
10.7
Neutral
STOCH(9,6)
35.63
Neutral
STOCH RSI (14)
46.25
Neutral
ADX(9)
20.35
Bearish
UO(9)
48.91
Neutral
ROC(12)
-2.89
Bearish
WillR(14)
-64.37
Neutral
Period
Simple value
Exponential vaue
5D
221.69
219.18
10D
218.97
220.23
20D
222.75
222.69
50D
230.5
226.44
100D
228.68
223.5
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct2L
28 Oct1L
27 Oct0L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Jagsonpal Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Jagsonpal Pharmaceuticals

Fund name
AUM
Bandhan BSE Healthcare Index Fund
0.02%

Jagsonpal Pharmaceuticals Returns Calculator

Ex-date: 04 Sep 2026

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Jagsonpal Pharmaceuticals Share Price FAQs

Please be aware that Jagsonpal Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.